Transferrin: structure, function and potential therapeutic actions (Q36039943)

11 August 2017

1 reference

title

Transferrin: structure, function and potential therapeutic actions (English)

1 reference

11 August 2017

Peter T Gomme

1

1 reference

PubMed ID

15708745

11 August 2017

Karl B McCann

series ordinal

2

1 reference

PubMed ID

15708745

11 August 2017

Joseph Bertolini

series ordinal

3

1 reference

11 August 2017

1 February 2005

1 reference

11 August 2017

1 reference

11 August 2017

10

1 reference

11 August 2017

4

1 reference

11 August 2017

267-273

1 reference

Function and therapeutic development of apotransferrin

11 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Two high-resolution crystal structures of the recombinant N-lobe of human transferrin reveal a structural change implicated in iron release

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

The structural mechanism for iron uptake and release by transferrins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

The chloride effect is related to anion binding in determining the rate of iron release from the human transferrin N-lobe

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

A comparison of the structure and properties of normal human transferrin and a genetic variant of human transferrin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Effect of transferrin polymorphism on the metabolism of vitamin C in Zimbabwean adults

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transferrin C2 variant does not confer a risk for Alzheimer's disease in Koreans.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transgenic mice as a model to study the regulation of human transferrin expression in Sertoli cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transferrin gene expression and secretion in rat sertoli cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transferrin gene expression visualized in oligodendrocytes of the rat brain by using in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Differences in transferrin response and numbers of transferrin receptors in rat and human mammary carcinoma lines of different metastatic potentials.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transferrin modifications and lipid peroxidation: implications in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transferrin/transferrin receptor-mediated drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transferrin's mechanism of interaction with receptor 1

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Intravesicular pH and iron uptake by immature erythroid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Apotransferrin administration prevents growth of Staphylococcus epidermidis in serum of stem cell transplant patients by binding of free iron

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

The inhibitory activity of serum to prevent bacterial adhesion is mainly due to apo-transferrin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Class specificity of transferrin as a muscle trophic factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Induction of bud formation of embryonic mouse tracheal epithelium by fibroblast growth factor plus transferrin in mesenchyme-free culture.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Apotransferrin Decreases Migration and Enhances Differentiation of Oligodendroglial Progenitor Cells in an in vitro System

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Thyroid hormone-dependent pituitary tumor cell growth in serum-free chemically defined culture. A new regulatory role for apotransferrin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Neurotrophic effects of transferrin on embryonic chick brain and neural retinal cell cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Differential effects of apotransferrin on two populations of oligodendroglial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Ovotransferrin and ovotransferrin receptor expression during chondrogenesis and endochondral bone formation in developing chick embryo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

The role of trophic factors and autocrine/paracrine growth factors in brain metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Development of serum-free media for the growth of human gastrointestinal adenocarcinoma xenografts as primary tissue cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transferrin ensures survival of ovarian carcinoma cells when apoptosis is induced by TNFalpha, FasL, TRAIL, or Myc.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Pro-apoptotic and anti-apoptotic effects of transferrin and transferrin-derived glycans on hematopoietic cells and lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Prevention of Fas-mediated hepatic failure by transferrin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transferrin is an insulin-like growth factor-binding protein-3 binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Congenital atransferrinemia in a 7-year-old girl

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transferrin-Immune Complex Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Oxidative stress and neutrophil activation--the two keystones of ischemia/reperfusion injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Ischemia, reperfusion, and the role of surgery in the treatment of cardiogenic shock secondary to acute myocardial infarction: an interpretative review

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Pathogenesis of renal ischemia/reperfusion injury: lessons from knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Role of apoptosis in hypoxic/ischemic damage in the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Kupffer's cells modulate neutrophile activity by superoxide anion and tumor necrosis factor-delta in reperfusion injury of liver transplantation-mechanisms of radical generation and reperfusion injury after cold ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Levels of some acute-phase proteins in the serum of patients with cancer during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Effects of in vitro glycation on Fe3+ binding and Fe3+ isoforms of transferrin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Nontransferrin-bound iron in serum of patients receiving bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Effective binding of free iron by a single intravenous dose of human apotransferrin in haematological stem cell transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transferrin as a metal ion mediator

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

In vivo distribution and speciation of [114mIn]InCl3 in the Wistar rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Pharmacokinetics and toxicity of bismuth compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Biological role of adduct formation of the ruthenium(III) complex NAMI-A with serum albumin and serum transferrin.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

99mTc-labelled human serum transferrin for tumour imaging: an in vitro and in vivo study of the complex

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transferrin trojan horses as a rational approach for the biological delivery of therapeutic peptide domains

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Effects of insulin and transferrin on the generation of lymphokine-activated killer cells in serum-free medium

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Therapeutic potential of vitamin D-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Development of a pharmaceutical apotransferrin product for iron binding therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

Inequivalence of the Two Tyrosine Ligands in the N-Lobe of Human Serum Transferrin†

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2804%2903333-1

7 January 2021

10.1016/S1359-6446(04)03333-1

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15708745